Business Description
Shanghai No 1 Pharmacy Co Ltd
NAICS : 446110
SIC : 5912
ISIN : CNE000000412
Share Class Description:
SHSE:600833: Class ACompare
Compare
Traded in other countries / regions
600833.China IPO Date
1994-02-24Description
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.41 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 1.04 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.1 | |||||
| Beneish M-Score | -1.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.3 | |||||
| 3-Year EBITDA Growth Rate | 20.4 | |||||
| 3-Year EPS without NRI Growth Rate | -37 | |||||
| 3-Year FCF Growth Rate | -15 | |||||
| 3-Year Book Growth Rate | 10.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.01 | |||||
| 9-Day RSI | 25.56 | |||||
| 14-Day RSI | 33.05 | |||||
| 6-1 Month Momentum % | 27.01 | |||||
| 12-1 Month Momentum % | 12.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.73 | |||||
| Quick Ratio | 1.18 | |||||
| Cash Ratio | 0.56 | |||||
| Days Inventory | 77.87 | |||||
| Days Sales Outstanding | 48.41 | |||||
| Days Payable | 98.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.05 | |||||
| Dividend Payout Ratio | 0.78 | |||||
| 3-Year Dividend Growth Rate | 37.5 | |||||
| Forward Dividend Yield % | 1.05 | |||||
| 5-Year Yield-on-Cost % | 2.58 | |||||
| Shareholder Yield % | 2.06 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.51 | |||||
| Operating Margin % | -0.65 | |||||
| Net Margin % | 9.67 | |||||
| FCF Margin % | -15.51 | |||||
| ROE % | 17.08 | |||||
| ROA % | 9.49 | |||||
| ROIC % | -0.93 | |||||
| 3-Year ROIIC % | -43.86 | |||||
| ROC (Joel Greenblatt) % | 68.18 | |||||
| ROCE % | 19.73 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.99 | |||||
| PE Ratio without NRI | 75.25 | |||||
| Shiller PE Ratio | 34.4 | |||||
| Price-to-Owner-Earnings | 16.79 | |||||
| PEG Ratio | 1.53 | |||||
| PS Ratio | 1.45 | |||||
| PB Ratio | 2.4 | |||||
| Price-to-Tangible-Book | 2.48 | |||||
| EV-to-EBIT | 10.76 | |||||
| EV-to-EBITDA | 10.76 | |||||
| EV-to-Revenue | 1.41 | |||||
| EV-to-FCF | -9.04 | |||||
| Price-to-Projected-FCF | 2.05 | |||||
| Price-to-Median-PS-Value | 0.85 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3 | |||||
| Price-to-Graham-Number | 2.87 | |||||
| Price-to-Net-Current-Asset-Value | 9.38 | |||||
| Earnings Yield (Greenblatt) % | 9.29 | |||||
| FCF Yield % | -10.7 | |||||
| Forward Rate of Return (Yacktman) % | 21.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai No 1 Pharmacy Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,852.588 | ||
| EPS (TTM) (Â¥) | 0.803 | ||
| Beta | 0.9 | ||
| Volatility % | 26.51 | ||
| 14-Day RSI | 33.05 | ||
| 14-Day ATR (Â¥) | 0.628799 | ||
| 20-Day SMA (Â¥) | 13.85 | ||
| 12-1 Month Momentum % | 12.47 | ||
| 52-Week Range (Â¥) | 7.91 - 17.66 | ||
| Shares Outstanding (Mil) | 223.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai No 1 Pharmacy Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai No 1 Pharmacy Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai No 1 Pharmacy Co Ltd Frequently Asked Questions
What is Shanghai No 1 Pharmacy Co Ltd(SHSE:600833)'s stock price today?
The current price of SHSE:600833 is ¥12.04. The 52 week high of SHSE:600833 is ¥17.66 and 52 week low is ¥7.91.
When is next earnings date of Shanghai No 1 Pharmacy Co Ltd(SHSE:600833)?
The next earnings date of Shanghai No 1 Pharmacy Co Ltd(SHSE:600833) is .
Does Shanghai No 1 Pharmacy Co Ltd(SHSE:600833) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai No 1 Pharmacy Co Ltd(SHSE:600833) is 1.05% (As of Today), Highest Dividend Payout Ratio of Shanghai No 1 Pharmacy Co Ltd(SHSE:600833) was 3.9. The lowest was 0.11. And the median was 0.38. The  Forward Dividend Yield % of Shanghai No 1 Pharmacy Co Ltd(SHSE:600833) is 1.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers